170 related articles for article (PubMed ID: 22535460)
1. [Intensive blood glucose control in type 2 diabetes: it is confirmed that the risk of severe hypoglycemias increases].
Steurer J
Praxis (Bern 1994); 2012 Apr; 101(9):617-8. PubMed ID: 22535460
[No Abstract] [Full Text] [Related]
2. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
Lambiel J; Fumeaux T
Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
[No Abstract] [Full Text] [Related]
3. [Is an intensive glycaemic control beneficial in diabetes type 2?].
Martin S
Dtsch Med Wochenschr; 2011 Sep; 136(39):1940. PubMed ID: 21948602
[No Abstract] [Full Text] [Related]
4. Everyone should watch glycosated hemoglobin and blood sugar levels, not just diabetics, research says.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Oct; 15(20):1-2, 5-6. PubMed ID: 15505932
[No Abstract] [Full Text] [Related]
5. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Riddle MC
Circulation; 2010 Aug; 122(8):844-6. PubMed ID: 20733112
[No Abstract] [Full Text] [Related]
6. Hyperglycemia and cardiovascular risk in NIDDM.
Uusitupa MI; Niskanen LK
Diabetes Care; 1995 Jun; 18(6):884-5. PubMed ID: 7555522
[No Abstract] [Full Text] [Related]
7. [Intensive glucose control in type 2 diabetes is beneficial].
Nilsson PM; Attvall S
Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
[No Abstract] [Full Text] [Related]
8. Glycemic control and cardiovascular disease: what's a doctor to do?
Kishore P; Kim SH; Crandall JP
Curr Diab Rep; 2012 Jun; 12(3):255-64. PubMed ID: 22467273
[TBL] [Abstract][Full Text] [Related]
9. Self monitoring of blood glucose in type 2 diabetes.
Gulliford M
BMJ; 2008 May; 336(7654):1139-40. PubMed ID: 18420661
[TBL] [Abstract][Full Text] [Related]
10. [Comment from the diabetology viewpoint].
Stahl M
Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
[No Abstract] [Full Text] [Related]
11. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR.
Schernthaner G
Wien Med Wochenschr; 2010 Jan; 160(1-2):8-19. PubMed ID: 20229156
[TBL] [Abstract][Full Text] [Related]
12. Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials.
Buehler AM; Cavalcanti AB; Berwanger O; Figueiro M; Laranjeira LN; Zazula AD; Kioshi B; Bugano DG; Santucci E; Sbruzzi G; Guimaraes HP; Carvalho VO; Bordin SA
Cardiovasc Ther; 2013 Jun; 31(3):147-60. PubMed ID: 22212499
[TBL] [Abstract][Full Text] [Related]
13. Glycemic Measures and Risk of Mortality in Older Chinese: The Guangzhou Biobank Cohort Study.
Jiang CQ; Xu L; Lam TH; Jin YL; Sen Zhang W; Zhu F; Thomas GN; Cheng KK
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31679008
[TBL] [Abstract][Full Text] [Related]
14. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
15. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
16. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: A long-term historical cohort study in Japan.
Takao T; Takahashi K; Suka M; Suzuki N; Yanagisawa H
Diabetes Res Clin Pract; 2019 Feb; 148():152-159. PubMed ID: 30641172
[TBL] [Abstract][Full Text] [Related]
17. Is there a need to optimize glycemic control in hemodialyzed diabetic patients?
Feldt-Rasmussen B
Kidney Int; 2006 Oct; 70(8):1392-4. PubMed ID: 17024163
[TBL] [Abstract][Full Text] [Related]
18. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
Orsi E; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Gruden G; Morano S; Nicolucci A; Penno G; Pugliese G;
Diabetes Obes Metab; 2018 Aug; 20(8):1885-1893. PubMed ID: 29582548
[TBL] [Abstract][Full Text] [Related]
19. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2011 Jun; (6):CD008143. PubMed ID: 21678374
[TBL] [Abstract][Full Text] [Related]
20. [Excessive mortality in diabetic patients is not a general phenomenon].
Holzgreve H
MMW Fortschr Med; 2016 May; 158(9):35. PubMed ID: 27155699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
